Literature DB >> 32446021

A population-based study of risk factors for heart failure in pediatric and adult-onset systemic lupus erythematosus.

Joyce C Chang1, Rui Xiao2, Andrea M Knight3, Stephen E Kimmel4, Laura M Mercer-Rosa5, Pamela F Weiss6.   

Abstract

OBJECTIVES: The increased relative risk of heart failure (HF) from systemic lupus erythematosus (SLE) is greatest at younger ages, but the etiology remains unclear. We identified risk factors for HF in children and adults with SLE and evaluated associations between SLE manifestations and HF.
METHODS: Incident SLE cases without preceding HF were identified using Clinformatics DataMart® (OptumInsight, Eden Prairie, MN) US claims data (2000-2015), and categorized by age of SLE onset (children 5-17, young adults 18-24, adults 25-44 years old). The primary outcome was the first HF ICD-9-CM diagnosis code (428.x), categorized as early-onset (< 6 months) or delayed-onset. Multivariable logistic regression was used to identify factors associated with early or delayed-onset HF. Cox proportional hazards regression was used to identify time-dependent associations between the onset of SLE manifestations and incident HF.
RESULTS: There were 523 (2.3%) HF cases among 1,466 children, 2,163 young adults and 19,349 adults age 25-44 with SLE. HF in children and young adults was early-onset in 50% and 60% of cases, respectively, compared to 35% of cases in adults 25-44 years old. There was a temporal association between incident myopericarditis and valvular disease diagnoses and early-onset HF, whereas nephritis and hypertension were more strongly associated with delayed-onset HF. Black race remained independently associated with a 1.5-fold increased HF risk at any time.
CONCLUSION: Hypertension remains an important traditional CV risk factor across all ages and should be managed aggressively even in younger patients with SLE. Cardiac dysfunction due to acute cardiac manifestations of SLE may contribute to the very high relative incidence of early HF diagnoses among younger SLE patients. Therefore, future prospective studies will need to address heterogeneity in the types and severity of heart failure in order to determine etiology and which patients should be monitored.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiac disease; Heart failure; Pediatric lupus; Systemic lupus erythematosus

Mesh:

Year:  2020        PMID: 32446021      PMCID: PMC7492402          DOI: 10.1016/j.semarthrit.2020.03.019

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  43 in total

1.  Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect.

Authors:  E Cairoli; M Rebella; N Danese; V Garra; E F Borba
Journal:  Lupus       Date:  2012-05-28       Impact factor: 2.911

2.  American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.

Authors:  Bevra H Hahn; Maureen A McMahon; Alan Wilkinson; W Dean Wallace; David I Daikh; John D Fitzgerald; George A Karpouzas; Joan T Merrill; Daniel J Wallace; Jinoos Yazdany; Rosalind Ramsey-Goldman; Karandeep Singh; Mazdak Khalighi; Soo-In Choi; Maneesh Gogia; Suzanne Kafaja; Mohammad Kamgar; Christine Lau; William J Martin; Sefali Parikh; Justin Peng; Anjay Rastogi; Weiling Chen; Jennifer M Grossman
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-06       Impact factor: 4.794

3.  Cardiovascular disease complications in systemic lupus erythematosus.

Authors:  Alexander Torres; Ali D Askari; Charles J Malemud
Journal:  Biomark Med       Date:  2009-06       Impact factor: 2.851

4.  Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project.

Authors:  D C Goff; D K Pandey; F A Chan; C Ortiz; M Z Nichaman
Journal:  Arch Intern Med       Date:  2000-01-24

5.  Heart failure risk in systemic lupus erythematosus compared to diabetes mellitus and general medicaid patients.

Authors:  Sarah K Chen; Medha Barbhaiya; Michael A Fischer; Hongshu Guan; Kazuki Yoshida; Candace H Feldman; Karen H Costenbader; Brendan M Everett
Journal:  Semin Arthritis Rheum       Date:  2019-06-11       Impact factor: 5.532

6.  Prevalence of and factors associated with hypertension in young and old women with systemic lupus erythematosus.

Authors:  José Mario Sabio; José Antonio Vargas-Hitos; Nuria Navarrete-Navarrete; Juan Diego Mediavilla; Juan Jiménez-Jáimez; Antonio Díaz-Chamorro; Juan Jiménez-Alonso
Journal:  J Rheumatol       Date:  2011-03-16       Impact factor: 4.666

Review 7.  Myocarditis in auto-immune or auto-inflammatory diseases.

Authors:  Cloé Comarmond; Patrice Cacoub
Journal:  Autoimmun Rev       Date:  2017-05-29       Impact factor: 9.754

8.  Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population.

Authors:  Linda T Hiraki; Candace H Feldman; Jun Liu; Graciela S Alarcón; Michael A Fischer; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2012-08

9.  Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.

Authors:  Candace H Feldman; Linda T Hiraki; Jun Liu; Michael A Fischer; Daniel H Solomon; Graciela S Alarcón; Wolfgang C Winkelmayer; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2013-03

Review 10.  Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective.

Authors:  M Petri
Journal:  Scand J Rheumatol       Date:  1996       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.